Debiopharm

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Debiopharm Group
Société Anonyme
Industry biopharmaceutical
Founded Lausanne, Switzerland (1979)
Founder Dr Rolland-Yves Mauvernay
Headquarters Lausanne, Switzerland
Area served
Worldwide
Key people
  • Rolland-Yves Mauvernay (Co-President)
  • Thierry Mauvernay (Co-President)
  • Bertrand Ducrey (CEO Debiopharm International SA)
  • Cédric Sager (CEO Debiopharm Research & Manufacturing SA)
  • Valérie Calvayrac (CEO Debiopharm Investment SA)
Products
Owner family-owned
Number of employees
350
Slogan We develop for patients
Website www.debiopharm.com

Debiopharm Group (Debiopharm) is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. It was founded in 1979 by Rolland-Yves Mauvernay.[1]

The group works through its subsidiaries:[2]

  • Debiopharm International SA, which in-licenses product candidates or technologies, develops them, and then licenses them to third parties for commercialization;[3]
  • Debiopharm Research and Manufacturing SA, which provides contract manufacturing and contract research services to Debiopharm;[4]
  • Debiopharm Investment SA, which manages the group's money and invests in real estate and in other companies; and[5]
  • Debiopharm Diagnostics SA, which invests in diagnostics companies.[6]

As of 2010 two drugs had reached the market through its efforts: oxaliplatin for the treatment of cancer, and depot formulations of triptorelin, a gonadotropin-releasing hormone agonist that is used to treat prostate cancer and pedophilia in men, and in women, breast cancer, ovarian cancer, endometriosis, uterine fibromyomas, precocious puberty, and female infertility.[7]

References[edit]

  1. ^ Bloomberg profile: Debiopharm Group. Page accessed May 12, 2016
  2. ^ Frost & Sullivan Nov 25 2010 Movers & Shakers Interview with Maurice Wagner, Debiopharm Group
  3. ^ Bloomberg profile: Debiopharm International. Page accessed May 12, 2016
  4. ^ Bernard Tappy for In Vivo Magazine. 2013 Debiopharm Research and Manufacturing SA.
  5. ^ Swiss Private Equity & Corporate Finance Association Debiopharm Investment SA Page accessed May 12, 2016
  6. ^ Bloomberg profile: Debiopharm Diagnostics. Page accessed May 12, 2016
  7. ^ Press release: Frost & Sullivan Confers European Biopharmaceuticals Company of the Year Award on Debiopharm Group.

External links[edit]

Coordinates: 46°30′54″N 6°38′28″E / 46.51500°N 6.64111°E / 46.51500; 6.64111